FDA’s Pre-Approval Inspections Fell by More Than 50 Percent in 2021, Report Says

By PacConAdmin | February 23, 2022

The FDA’s Office of Pharmaceutical Quality (OPQ) used alternative tools because of the ongoing pandemic that reduced the number of facilities needing pre-approval inspections by more than 50 percent in fiscal 2021, OPQ said in its annual report released yesterday.
Source: Drug Industry Daily

Posted in Drug Industry Daily